Inventor
BRANDT GARY E L
US22 patents
⚠️ This page may combine multiple inventors who share the name “BRANDT GARY E L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
20 patentsUS10196393B2Feb 5, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC24 citations98
US10550118B2Feb 4, 2020
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC13 citations94
US10526330B2Jan 7, 2020
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10519153B2Dec 31, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC16 citations94
US10392386B2Aug 27, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC19 citations94
US10208040B2Feb 19, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC24 citations94
US9725470B2Aug 8, 2017
Substituted naphthyridines as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US10308646B2Jun 4, 2019
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC11 citations92
US11420965B2Aug 23, 2022
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US11254669B2Feb 22, 2022
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10954237B2Mar 23, 2021
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US10562894B2Feb 18, 2020
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US10913740B2Feb 9, 2021
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC5 citations83
US11453668B2Sep 27, 2022
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11299492B2Apr 12, 2022
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US12358931B2Jul 15, 2025
3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US12172994B2Dec 24, 2024
Pyrimidine compound as JAK kinase inhibitor
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11878977B2Jan 23, 2024
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11718616B2Aug 8, 2023
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11667637B2Jun 6, 2023
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations62